Travoprost Implant with iStent for Open-Angle Glaucoma
Travoprost Intraocular Implant + iStent Infinite
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- Glaukos Corporation · Industry
This trial is looking for adults with high eye pressure due to open-angle glaucoma or ocular hypertension. Participants will receive either a new treatment with an iStent or a sham procedure along with a travoprost implant, and they will be monitored for 12 months.
You may be able to join if
- I have open-angle glaucoma or high eye pressure.
You may not be able to join if
- I have untreated eye pressure over 36 mmHg.
- I am allergic to travoprost or its ingredients.
- I have a vertical cup/disc ratio greater than 0.8 in my study eye.
- I have vision worse than 20/80 in either eye.
- I have any eye condition that may significantly affect my safety or the trial results.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityAdult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Loading trial locations…